Adherence to HIV pre-exposure prophylaxis (PrEP) among key populations (KPs): an analytical cross-sectional study in Matayos Sub County, Busia County, Kenya

Authors

  • Joseph Wanyama Barasa Department of Epidemiology and Biostatistics, School of Public Health, Mount Kenya University, Thika, Kenya
  • Atei Kerochi Department of Epidemiology and Biostatistics, School of Public Health, Mount Kenya University, Thika, Kenya
  • Dominic Mogere Department of Epidemiology and Biostatistics, School of Public Health, Mount Kenya University, Thika, Kenya

DOI:

https://doi.org/10.18203/2394-6040.ijcmph20231266

Keywords:

Key populations and adherence, Pre-exposure prophylaxis

Abstract

Background: A large percentage of the new cases of HIV/AIDs in Kenya are attributed to Key Populations (KPs). In Kenya, KPs contribute 33% of all new infections of HIV. It is with this realization that in 2017 the government of Kenya launched The Pre-Exposure Prophylaxis (PrEP) for HIV. The study aimed at assessing the factors influencing adherence to PrEP by KPs in Matayos sub-county, Busia County, Kenya.

Methods: An analytical cross-sectional study that utilized a mixed-method data collection approach (n=343) was used to assessing the factors influencing adherence to PrEP by KPs in Matayos sub-county, Busia County, Kenya.

Results: The level of adherence to PrEP using the Morisky Medical Adherence Scale-4 was established to be 37% among all KPs and 36%, 37% and 52% among CSWs, MSMs and PWIDs respectively. Chi-square analysis revealed significant relationship between Level of education (p=0.05), marital status (p=0.001), KP category (p=0.034), occupation (p=0.014), stigma (p=0.00), the perceptions of side effects (p=0.011), facility accessibility (P= 0.00), side effects (p=0.001) and adherence to PrEP. Among the MSMs condom use was established to have association to PrEP adherence (p=0.00).

Conclusions: The study concluded that socio-demographic, individual characteristics, and clinical factors influence adherence to pre-exposure prophylaxis among key populations. The study recommended that key populations need more information on how to use pre-exposure prophylaxis, how it works, the side effects, what to do in case they experience the side effects and why adherence to pre-exposure prophylaxis is important.

Metrics

Metrics Loading ...

References

UNAIDS D, Update AE. Geneva: Joint United Nations Programme on HIV. Aids. 2019;566.

Moise IK, de Joya E, Zulu LC, Kalipeni E, Grigsby-Toussaint DS. Progress towards combatting HIV/AIDS in Africa. Public Health, Disease and Development in Africa: Routledge. 2018:60-78.

Musyoki H, Bhattacharjee P, Sabin K, Ngoksin E, Wheeler T, Dallabetta G. A decade and beyond: learnings from HIV programming with underserved and marginalized key populations in Kenya. J Internat AIDS Soci. 2021;24:e25729.

Jones G, Jones G. HIV as an Urban Epidemic. HIV and Young People: Risk and Resilience in the Urban Slum. 2016:51-66.

Kharsany AB, Karim QA. HIV infection and AIDS in sub-Saharan Africa: current status, challenges and opportunities. The Open AIDS J. 2016;10:34-48.

Mitchell KM, Prudden HJ, Washington R, Isac S, Rajaram SP, Foss AM, et al. Potential impact of pre‐exposure prophylaxis for female sex workers and men who have sex with men in Bangalore, India: a mathematical modelling study. J Intern AIDS Soci. 2016;19(1):20942.

Mpondo BC, Gunda DW, Kilonzo SB. HIV epidemic in Tanzania: the possible role of the key populations. AIDS Res Treat. 2017;2017.

Qu D, Zhong X, Xiao G, Dai J, Liang H, Huang A. Adherence to pre-exposure prophylaxis among men who have sex with men: A prospective cohort study. Internat J Infect Dis. 2018;75:52-9.

Arkell C. Research Update: Meta-analysis shows PrEP is effective in women with high adherence. Canadian AIDS Treatment Information Exchange. 2017.

Haberer JE. Current concepts for PrEP adherence: In the PrEP revolution; from clinical trials to routine practice. Current Op HIV AIDS. 2016;11(1):10.

Mwaura SM. Determinants of Adherence Levels to Oral Pre-exposure Prophylaxis Among Seronegative Partners in Hiv Discordant Heterosexual Relationships (Doctoral dissertation, University of Nairobi). 2019.

Koss CA, Charlebois ED, Ayieko J, Kwarisiima D, Kabami J, Balzer LB, et al. Uptake, engagement, and adherence to pre-exposure prophylaxis offered after population HIV testing in rural Kenya and Uganda: 72-week interim analysis of observational data from the SEARCH study. The Lancet HIV. 2020;7(4):e249-e61.

Moseholm E, Gilleece Y, Collins B, Kowalska JD, Vasylyev M, Elía MJ, et al. Achievements and gaps to provide pre-exposure prophylaxis (PrEP) for women across the European Region–results from a European survey study. J Virus Eradicat. 2021;7(1):100026.

Roche SD, Wairimu N, Mogere P, Kamolloh K, Odoyo J, Kwena ZA, et al. Acceptability and feasibility of Pharmacy-Based delivery of pre-exposure prophylaxis in Kenya: a qualitative study of client and provider perspectives. AIDS Behavior. 2021;25:1-12.

Moseholm E, Gilleece Y, Collins B, Kowalska JD, Vasylyev M, Elía MJ, et al. Achievements and gaps to provide pre-exposure prophylaxis (PrEP) for women across the European Region–results from a European survey study. J Virus Eradicat. 2021;7(1):100026.

Wahome EW, Graham SM, Thiong'o AN, Mohamed K, Oduor T, Gichuru E, et al. PrEP uptake and adherence in relation to HIV-1 incidence among Kenyan men who have sex with men. E Clinical Medicine. 2020;26:100541.

Marins LM, Torres TS, Leite IdC, Moreira RI, Luz PM, Hoagland B, et al. Performance of HIV pre-exposure prophylaxis indirect adherence measures among men who have sex with men and transgender women: Results from the PrEP Brasil Study. PLoS One. 2019;14(8):e0221281.

Pillay D, Stankevitz K, Lanham M, Ridgeway K, Murire M, Briedenhann E, et al. Factors influencing uptake, continuation, and discontinuation of oral PrEP among clients at sex worker and MSM facilities in South Africa. PloS one. 2020;15(4):e0228620.

Storholm ED, Volk JE, Marcus JL, Silverberg MJ, Satre DD. Risk perception, sexual behaviors, and PrEP adherence among substance-using men who have sex with men: A qualitative study. Prevention Science. 2017;18:737-47.

Grov C, Rendina HJ, John SA, Parsons JT. Determining the roles that club drugs, marijuana, and heavy drinking play in PrEP medication adherence among gay and bisexual men: implications for treatment and research. AIDS and Behavior. 2019;23:1277-86.

Arnold T, Brinkley-Rubinstein L, Chan PA, Perez-Brumer A, Bologna ES, Beauchamps L, et al. Social, structural, behavioral and clinical factors influencing retention in Pre-Exposure Prophylaxis (PrEP) care in Mississippi. PloS one. 2017;12(2):e0172354.

Grant H, Mukandavire Z, Eakle R, Prudden H, B Gomez G, Rees H, et al. When are declines in condom use while using PrEP a concern? Modelling insights from a Hillbrow, South Africa case study. J Internat AIDS Soci. 2017;20(1):21744.

WHO. Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV, 2015. Available at: https://www.who.int/ publications/i/item/9789241509565. Accessed 02 February 2023.

Downloads

Published

2023-04-28

How to Cite

Barasa, J. W., Kerochi, A., & Mogere , D. (2023). Adherence to HIV pre-exposure prophylaxis (PrEP) among key populations (KPs): an analytical cross-sectional study in Matayos Sub County, Busia County, Kenya. International Journal Of Community Medicine And Public Health, 10(5), 1697–1704. https://doi.org/10.18203/2394-6040.ijcmph20231266

Issue

Section

Original Research Articles